Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q18358151> ?p ?o }
Showing triples 1 to 26 of
26
with 100 triples per page.
- Q18358151 subject Q15405871.
- Q18358151 subject Q7151811.
- Q18358151 subject Q8754940.
- Q18358151 abstract "Imvanex (Modified Vaccinia Ankara – Bavarian Nordic) is a non-replicating smallpox vaccine developed and manufactured by Bavarian Nordic. It was approved in the European Union for active immunization against smallpox disease in adults in 2013, and has also been approved in Canada where it is marketed as Imvamune. On its path for the approval in the U.S., Imvamune undergoes additional series of evaluation studies.Imvanex contains a modified form of the vaccinia virus, Modified vaccinia Ankara, which does not replicate in human cells and hence does not cause the serious side effects that are seen with replicating smallpox vaccines. These replicating vaccines use different strains of the vaccinia virus, which all replicate in humans, and are not recommended for persons with immune deficiencies and exfoliative skin disorders such as eczema or atopic dermatitis. Vaccines containing vaccinia viruses were used effectively in the campaign to eradicate smallpox. Because of similarities between vaccinia and the smallpox virus, the antibodies produced against vaccinia have been shown to protect against smallpox. In contrast to replicating smallpox vaccines, which are applied by scarification using a bifurcated needle, Imvanex is administered by injection via the subcutaneous route.".
- Q18358151 atcPrefix "J07".
- Q18358151 atcSuffix "BX".
- Q18358151 wikiPageExternalLink WC500147896.pdf.
- Q18358151 wikiPageExternalLink www.imvanex.com.
- Q18358151 wikiPageWikiLink Q1037810.
- Q18358151 wikiPageWikiLink Q12214.
- Q18358151 wikiPageWikiLink Q15405871.
- Q18358151 wikiPageWikiLink Q2035485.
- Q18358151 wikiPageWikiLink Q4904822.
- Q18358151 wikiPageWikiLink Q6889412.
- Q18358151 wikiPageWikiLink Q7151811.
- Q18358151 wikiPageWikiLink Q812002.
- Q18358151 wikiPageWikiLink Q8754940.
- Q18358151 atcPrefix "J07".
- Q18358151 atcSuffix "BX".
- Q18358151 type ChemicalSubstance.
- Q18358151 type Drug.
- Q18358151 type ChemicalObject.
- Q18358151 type Thing.
- Q18358151 type Q8386.
- Q18358151 comment "Imvanex (Modified Vaccinia Ankara – Bavarian Nordic) is a non-replicating smallpox vaccine developed and manufactured by Bavarian Nordic. It was approved in the European Union for active immunization against smallpox disease in adults in 2013, and has also been approved in Canada where it is marketed as Imvamune.".
- Q18358151 label "Imvanex".